Innoviva (NASDAQ: INVA) reported Q2 EPS of $0.30, $0.03 better than the analyst estimate of $0.27. Revenue for the quarter came in at $58.6 million versus the consensus estimate of $50.53 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.